Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 17 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Nasopharyngeal Carcinoma 3 Recurrence 2 Non-Muscle Invasive Bladder Neoplasms 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Neoplasms 1 Thromboembolism 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Malnutrition 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Infiltrating Bladder Urothelial Carcinoma 1 Immunoblastic Lymphadenopathy 1 Hypoxia 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1

Interventions

fluoroazomycin arabinoside 3 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 Propofol 2 gadobutrol 1 Sevoflurane 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Oxygen 1 Ketamine 1 Gemcitabine 1 Furosemide 1 Exercise 1 Diagnostic Imaging 1 Blood Specimen Collection 1 Biopsy 1 4-methylbenzenesulfonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01989000 2018-06-27

MIPA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed

Gastrointestinal

Hypoxia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡